Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges. Barua D, Gupta A, Gupta S. Cancer Lett 2020 May 21. pii: S0304-3835(20)30283.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Barua D, Gupta A, Gupta S. Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges. Cancer Lett 2020 May 21. pii: S0304-3835(20)30283.
PMID: 32446861